ASTEC LIFESCIENCES LIMITED

Astec LifeSciences Limited has announced its 32nd Annual General Meeting (AGM) to be held on Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also released its Annual Report for the Financial Year 2025-26, which includes audited financial statements, Board of Directors' reports, and Statutory Auditors' reports. The Annual Report is available on the company's website. Shareholders will be able to access the report via a weblink provided in letters sent to them. The Register of Members and Share Transfer Books will be closed from July 26 to July 30, 2026, for the AGM. Remote e-voting will be open from July 26 to July 30, 2026.

Astec Lifesciences Ltd has announced the closure of its Register of Members and Share Transfer Books from July 26 to July 30, 2026, for its 32nd Annual General Meeting (AGM). The AGM is scheduled for July 31, 2026, to be held via Video Conferencing. The company has also made its Annual Report for FY 2025-26 available on its website and via a weblink sent to shareholders. Remote e-voting will be open from July 26 to July 30, 2026, for shareholders as of the cut-off date, July 24, 2026.

Astec Lifesciences Ltd has announced its 32nd Annual General Meeting (AGM) to be held on Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also released its Annual Report for the Financial Year 2025-26, which includes audited financial statements and reports. The Annual Report is available on the company's website. The Register of Members and Share Transfer Books will be closed from July 26 to July 30, 2026, for the AGM. Remote e-voting will be open from July 26 to July 30, 2026, for shareholders as of the cut-off date, July 24, 2026.

Astec LifeSciences Limited has announced its 32nd Annual General Meeting (AGM) to be held on Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also released its Annual Report for the Financial Year 2025-26, which includes the audited financial statements and reports. The Register of Members and Share Transfer Books will be closed from July 26 to July 30, 2026, for the AGM. Remote e-voting will be open from July 26 to July 30, 2026, for shareholders as of the cut-off date of July 24, 2026.

Astec LifeSciences Limited has announced its 32nd Annual General Meeting (AGM) to be held on Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing/Other Audio Visual Means. The company has also released its Annual Report for the Financial Year 2025-26, which includes audited financial statements and reports. The Annual Report is available on the company's website. Shareholders will be able to access the report via a weblink provided in letters sent to them. The Register of Members and Share Transfer Books will be closed from July 26 to July 30, 2026, for the AGM. Remote e-voting will be open from July 26 to July 30, 2026, for shareholders as of the cut-off date of July 24, 2026.

Astec Lifesciences Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from Wednesday, July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. All officers and designated employees, including directors and auditors, are prohibited from trading in the company's equity shares during this period to prevent potential insider trading.

Astec Lifesciences Ltd announced the resignation of Ms. Vijayalakshmi Iyer, General Manager - Human Resources, effective June 5, 2026. She is leaving to pursue a new opportunity. The company has accepted her resignation and stated there are no other material reasons for her departure. Ms. Iyer has been a Senior Management Personnel at the company.

Astec Lifesciences Ltd. has responded to an exchange query regarding a significant increase in the volume of its security. The company confirms compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. Astec states that there are no undisclosed developments requiring mandatory disclosure and assures adherence to all applicable regulations.

Astec LifeSciences Limited's Nomination and Remuneration Committee has approved the grant of 1,142 stock options to an eligible grantee under the Astec LifeSciences Limited - Employees Stock Option Plan, 2012 (ESOP 2012). The exercise price for these options is set at ₹10 per option, with each option entitling the holder to one equity share of face value ₹10. The options will vest over a period of three years and are exercisable within one month from the date of vesting.

Astec Lifesciences' Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, with an unmodified opinion from statutory auditors. The 32nd Annual General Meeting (AGM) is scheduled for Friday, July 31, 2026, with book closure from July 26 to July 30, 2026. The Board also proposed seeking shareholder approval via postal ballot for the appointment of Mr. Vishal Sharma, Mr. Burjis N. Godrej, Mr. Arijit Mukherjee, and Mr. Mathew Eipe as directors, and for entering into material related party transactions during FY2026-27.